Revium Rx (RVRC)
OTCMKTS · Delayed Price · Currency is USD
0.5200
0.00 (0.00%)
Sep 16, 2025, 8:00 PM EDT
Revium Rx Company Description
Revium Rx, a pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates.
It develops nanoparticles-based formulation of a potent antibiotic; novel adjuvant for cancer therapies: and novel immunization based on liposomal protein-loaded technology.
The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024.
Revium Rx was incorporated in 1997 and is based in Herzliya, Israel.
Revium Rx
| Country | United States |
| Founded | 1997 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Amir Avraham |
Contact Details
Address: 10 HaMenofim St Herzliya , Nevada 4672561 Israel | |
| Phone | 1-800-5191687 |
| Website | reviumrx.com |
Stock Details
| Ticker Symbol | RVRC |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US76151C1009 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Amir Avraham CPA | Interim Chief Executive Officer |
| Inna Martin | President, Chief Operating Officer, Secretary and Director |
| Arie Gordashnikov C.P.A. | Chief Financial Officer and Treasurer |
| Dr. Erez Koren | Chief Technology Officer |